找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Essentials of Operative Cardiac Surgery; Prakash P. Punjabi,Panagiotis G. Kyriazis Book 2022Latest edition Springer Nature Switzerland AG

[復(fù)制鏈接]
樓主: 選民
11#
發(fā)表于 2025-3-23 12:23:04 | 只看該作者
Minimally Invasive Mitral Valve Repair/Replacement,many expert mitral valve repair centers. The technique is safe and efficient and its superiority to conventional sternotomy has been demonstrated in terms of postoperative bleeding, ICU and length of hospital stays. Results of the technique still remain dependent on the surgeon mastering the techniq
12#
發(fā)表于 2025-3-23 15:33:58 | 只看該作者
13#
發(fā)表于 2025-3-23 21:40:21 | 只看該作者
Ascending Aortic Aneurysm Surgery,nd incidentally. If left untreated, aneurysms can continue to grow, leading to eventual rupture and death. Current guidelines suggest threshold of 5.5 cm for surgical intervention in the absence of risk factors, however, any predisposing genetic factors lower this threshold. The fundamental principl
14#
發(fā)表于 2025-3-23 23:43:25 | 只看該作者
Ascending Aortic Dissection Surgery,d most experienced centers. Patients can present with cardiac tamponade, stroke, myocardial infarction, acute aortic insufficiency, or malperfusion involving various arterial beds. The key principles of the surgical management of ascending aortic dissection are to resect the intimal tear, to reestab
15#
發(fā)表于 2025-3-24 05:25:23 | 只看該作者
16#
發(fā)表于 2025-3-24 06:38:10 | 只看該作者
Coronary Artery Bypass Graft vs. Percutaneous Intervention,(CABG) continues. This chapter’s first section identifies what criteria should be evaluated when deciding upon revascularization strategy, including: surgical mortality, anatomical considerations, and the ability to achieve complete revascularization. The second section of the chapter reviews curren
17#
發(fā)表于 2025-3-24 11:19:39 | 只看該作者
18#
發(fā)表于 2025-3-24 17:20:15 | 只看該作者
Till Alexander Backsmann,Carmen BacksmannSIRS. Emerging therapies aiming to inhibit the uncontrolled inflammatory response during CPB may provide clinical benefit and reverse adverse clinical outcomes. Clinical observations and level of evidence will be reviewed.
19#
發(fā)表于 2025-3-24 21:58:46 | 只看該作者
20#
發(fā)表于 2025-3-25 03:08:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 23:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
林周县| 徐州市| 东明县| 都匀市| 津市市| 石台县| 电白县| 离岛区| 丰顺县| 西华县| 海晏县| 安新县| 西贡区| 措勤县| 彭山县| 扎囊县| 武定县| 班玛县| 淮阳县| 鲜城| 行唐县| 崇信县| 谷城县| 延吉市| 汾阳市| 英德市| 九龙城区| 鄄城县| 松潘县| 林西县| 盘山县| 石首市| 会东县| 江孜县| 宁河县| 靖江市| 长乐市| 泰州市| 建平县| 抚松县| 平乡县|